Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedMar 29, 2023
DataAggregated Company Financials
Companies10
  • 7D-2.7%
  • 3M-11.2%
  • 1Y-38.6%
  • YTD-12.8%

Over the last 7 days, the Pharma industry has dropped 2.7%, driven by a pullback from Searle of 5.3%. However, the industry is down 39% over the past year. As for the next few years, earnings are expected to grow by 40% per annum.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 Mar 2023PK₨139.7bPK₨191.5bPK₨15.1b9.4x9.3x0.7x
Fri, 24 Feb 2023PK₨142.4bPK₨189.4bPK₨15.2b9.2x9.3x0.8x
Sun, 22 Jan 2023PK₨138.5bPK₨189.4bPK₨15.2b8.8x9.1x0.7x
Tue, 20 Dec 2022PK₨167.7bPK₨189.4bPK₨15.2b10.1x11x0.9x
Thu, 17 Nov 2022PK₨190.0bPK₨187.5bPK₨14.9b12.5x12.7x1x
Sat, 15 Oct 2022PK₨198.4bPK₨181.2bPK₨17.2b11.8x11.5x1.1x
Mon, 12 Sep 2022PK₨201.7bPK₨172.4bPK₨18.5b11.7x10.9x1.2x
Wed, 10 Aug 2022PK₨210.2bPK₨169.3bPK₨21.5b10.2x9.8x1.2x
Fri, 08 Jul 2022PK₨214.7bPK₨167.9bPK₨21.4b10.9x10x1.3x
Sun, 05 Jun 2022PK₨204.2bPK₨165.2bPK₨21.4b9.4x9.6x1.2x
Tue, 03 May 2022PK₨222.1bPK₨163.7bPK₨21.2b10.1x10.5x1.4x
Thu, 31 Mar 2022PK₨227.6bPK₨159.8bPK₨19.6b11.1x11.6x1.4x
Sat, 26 Feb 2022PK₨228.8bPK₨160.5bPK₨20.0b11x11.4x1.4x
Mon, 24 Jan 2022PK₨239.7bPK₨160.5bPK₨20.0b11.5x12x1.5x
Wed, 22 Dec 2021PK₨234.5bPK₨160.5bPK₨20.0b11.5x11.7x1.5x
Fri, 19 Nov 2021PK₨259.8bPK₨160.5bPK₨20.0b12.9x13x1.6x
Sun, 17 Oct 2021PK₨268.2bPK₨155.0bPK₨19.5b13.7x13.8x1.7x
Tue, 14 Sep 2021PK₨280.4bPK₨153.6bPK₨18.7b13.9x15x1.8x
Thu, 12 Aug 2021PK₨280.5bPK₨153.6bPK₨18.7b13.4x15x1.8x
Mon, 07 Jun 2021PK₨261.6bPK₨140.6bPK₨16.9b14.8x15.5x1.9x
Sun, 28 Feb 2021PK₨278.1bPK₨135.4bPK₨15.2b16.7x18.3x2.1x
Wed, 02 Dec 2020PK₨254.9bPK₨132.1bPK₨13.3b19.6x19.1x1.9x
Sat, 05 Sep 2020PK₨268.4bPK₨125.7bPK₨12.1b24.1x22.3x2.1x
Tue, 09 Jun 2020PK₨213.4bPK₨124.5bPK₨9.7b19.6x22x1.7x
Price to Earnings Ratio

17.5x


Total Market Cap: PK₨169.8bTotal Earnings: PK₨9.7bTotal Revenue: PK₨124.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 14.6x202120222023
Current Industry PE
  • Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 9.3x which is lower than its 3-year average PE of 14.6x.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.73x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare industry?

PK Market-1.49%
Healthcare-2.36%
Pharma-2.66%
Pharma-2.66%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HINOON Highnoon LaboratoriesPK₨471.830.4%
+PK₨76.6m
-16.1%PE8.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SEARL

PK₨52.51

Searle

7D

-5.3%

1Y

-45.1%

SAPL

PK₨720.00

sanofi-aventis Pakistan

7D

-0.07%

1Y

-19.8%

AGP

PK₨54.09

AGP

7D

-4.2%

1Y

-37.9%

FEROZ

PK₨135.61

Ferozsons Laboratories

7D

-8.4%

1Y

-49.4%

CPHL

PK₨25.62

Citi Pharma

7D

-1.8%

1Y

-25.8%

HINOON

PK₨471.83

Highnoon Laboratories

7D

0.4%

1Y

-16.1%

META

PK₨5.89

MetaTech Health

7D

-3.4%

1Y

n/a

GLAXO

PK₨79.00

GlaxoSmithKline Pakistan

7D

-1.4%

1Y

-41.9%

ABOT

PK₨391.78

Abbott Laboratories (Pakistan)

7D

-1.8%

1Y

-43.6%